Manulife (Manufacturers Life Insurance)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.39M | Sell |
24,680
-7,686
| -24% | -$1.06M | ﹤0.01% | 1316 |
|
|
2025
Q1 | $5.84M | Sell |
32,366
-2,840
| -8% | -$512K | 0.01% | 1103 |
|
|
2024
Q4 | $5.52M | Buy |
35,206
+3,981
| +13% | +$624K | ﹤0.01% | 1156 |
|
|
2024
Q3 | $5.68M | Sell |
31,225
-9,790
| -24% | -$1.78M | 0.01% | 1158 |
|
|
2024
Q2 | $7.53M | Sell |
41,015
-283
| -0.7% | -$52K | 0.01% | 955 |
|
|
2024
Q1 | $7.35M | Buy |
41,298
+12,048
| +41% | +$2.14M | 0.01% | 1005 |
|
|
2023
Q4 | $3.63M | Buy |
29,250
+8,813
| +43% | +$1.09M | ﹤0.01% | 1294 |
|
|
2023
Q3 | $2.37M | Sell |
20,437
-1,192
| -6% | -$138K | ﹤0.01% | 1384 |
|
|
2023
Q2 | $2.54M | Buy |
21,629
+13,108
| +154% | +$1.54M | ﹤0.01% | 1338 |
|
|
2023
Q1 | $682K | Buy |
8,521
+36
| +0.4% | +$2.88K | ﹤0.01% | 1816 |
|
|
2022
Q4 | $672K | Buy |
8,485
+150
| +2% | +$11.9K | ﹤0.01% | 1814 |
|
|
2022
Q3 | $581K | Sell |
8,335
-187
| -2% | -$13K | ﹤0.01% | 1880 |
|
|
2022
Q2 | $560K | Buy |
8,522
+396
| +5% | +$26K | ﹤0.01% | 1977 |
|
|
2022
Q1 | $541K | Sell |
8,126
-1,201
| -13% | -$79.9K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $652 | Sell |
9,327
-210
| -2% | -$15 | ﹤0.01% | 2091 |
|
|
2021
Q3 | $498K | Sell |
9,537
-775
| -8% | -$40.5K | ﹤0.01% | 2286 |
|
|
2021
Q2 | $701K | Buy |
10,312
+1,595
| +18% | +$108K | ﹤0.01% | 2200 |
|
|
2021
Q1 | $672K | Buy |
8,717
+330
| +4% | +$25.4K | ﹤0.01% | 2111 |
|
|
2020
Q4 | $503K | Buy |
8,387
+604
| +8% | +$36.2K | ﹤0.01% | 2190 |
|
|
2020
Q3 | $335K | Buy |
7,783
+465
| +6% | +$20K | ﹤0.01% | 2219 |
|
|
2020
Q2 | $302K | Buy |
7,318
+449
| +7% | +$18.5K | ﹤0.01% | 2250 |
|
|
2020
Q1 | $297K | Buy |
6,869
+415
| +6% | +$17.9K | ﹤0.01% | 2100 |
|
|
2019
Q4 | $357K | Buy |
6,454
+83
| +1% | +$4.59K | ﹤0.01% | 2235 |
|
|
2019
Q3 | $226K | Buy |
6,371
+690
| +12% | +$24.5K | ﹤0.01% | 2503 |
|
|
2019
Q2 | $229K | Buy |
+5,681
| New | +$229K | ﹤0.01% | 2553 |
|